The Board of Directors is the governing body of NERGG. We gather Providers, Public Health officials, and consumers from the six New England states, to hear their unique perspectives as we work together to improve access to genetic services throughout the region.
President: Lisa Louise Brailey, MD, FACMG
Technical Director, Molecular Diagnostics & Clinical Trials
Dianon Pathology/LabCorp Specialty Testing Group, Shelton, CT
President-elect: Mary-Frances Garber, MS, CGC
Listening, Reflecting, Healing
Immediate Past President: Fay H. Larson, RN, MS, NC, Nurse Consultant
Treasurer: Samuel Drazin, Executive Director, Changing Perspectives
Bradford, VT email@example.com
Secretary: Margaret Emmet, MS, CGC
Boston, MA Margaret.Emmet@MGH.HARVARD.EDU
Catherine Nowak, M.D.
Feingold Center for Children, Massachusetts
David Harris, M.D.
Boston Children's Hospital, Massachusetts
Elicia Estrella, M.S., CGC (alternate)
Boston Children's Hospial, Massachusetts
Tom Brewster, M.D.
Maine Medical Center, Portland, ME
Holly Richards, MPH, CHES (alternate)
Office of Disease Control and Prevention, ME
Erica Stelmach, MS, CGC
Elliot Hospital, Manchester, NH
Lisa Demers, MS, CGC (alternate)
Ariosa Diagnostics, Bedford, NH
Jacquelyn Halliday, MS, CGC
Women and Infants Hospital, Providence, RI
Jennifer Schwab, MS, CGC
Rhode Island Hospital, Providence, RI
Sickle Cell Association of America, CT
Donna Maselli, RN, MPH
Department of Public Health, CT
Joseph Tucker, M.D.
UConn Health, CT
Cindy Ingham, RN, BSN
Vermont Department of Public Health, Burlington, VT
2018 Board Meetings
Members are welcome to attend board meetings as non-voting participants.
Wednesday, March 14th at 8:30am
Wednesday, June 13th at 12pm
Wednesday, September 12th at 12pm
Wednesday, November 28th at 6pm (in-person meeting)